SINGAPORE (CNA) – Pfizer’s Paxlovid has become the first oral tablet approved in Singapore for the treatment of COVID-19 in adult patients who are at risk of severe disease. Interim authorisation for the oral medicine was granted under the Pandemic Special Access Route (PSAR) on January 31, the Health Sciences Authority (HSA) said yesterday. “This
